The iconic rise of Viagra has consistently remained a symbol of pharmaceutical success, but its legacy within the broader sector now triggers questions about long-term returns . Copycat versions are eroding patent protection , causing anxieties that investing in companies closely tied to Viagra's former standing could be a speculative move , especi